« We have chosen Tandem 40μm for their small sizes and calibration as well as for size stability, post loading change being inferior to 5%. Among our expectations, a theoritical deeper penetration. So less risk of angiogenesis due to hypoxic effect »
Dr Giorgio Greco, Istituto Nazionale del Tumori, Milano.
Compared to recent publications, a trend to
Case report: use of 40 μm microspheres with doxorubicin in patient with hepatitis C cirrhosis and Child-Pugh classification C as bridging therapy
“Histological examinations showed the presence of doxorubicin beads within the interstitium of the tumour, the deepest level achievable.”
Hoi Lam She, Princess Margaret Hospital, Hong Kong
Sign up to receive periodic emails about Tumour Management related updates and keep your knowledge up to date.